MAZZINI, LETIZIA
 Distribuzione geografica
Continente #
EU - Europa 2.171
NA - Nord America 1.414
AS - Asia 355
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 2
OC - Oceania 1
Totale 3.955
Nazione #
US - Stati Uniti d'America 1.401
IE - Irlanda 753
IT - Italia 388
SE - Svezia 308
DE - Germania 284
UA - Ucraina 172
CN - Cina 102
FI - Finlandia 93
SG - Singapore 92
HK - Hong Kong 88
GB - Regno Unito 35
FR - Francia 34
CZ - Repubblica Ceca 29
NL - Olanda 25
IN - India 24
IR - Iran 21
BE - Belgio 18
PL - Polonia 13
CA - Canada 12
TR - Turchia 12
BR - Brasile 8
RO - Romania 8
JP - Giappone 7
CH - Svizzera 4
EU - Europa 3
ES - Italia 2
JO - Giordania 2
AT - Austria 1
AU - Australia 1
AZ - Azerbaigian 1
CL - Cile 1
DK - Danimarca 1
EG - Egitto 1
GR - Grecia 1
ID - Indonesia 1
IL - Israele 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
NG - Nigeria 1
PA - Panama 1
PH - Filippine 1
RU - Federazione Russa 1
TH - Thailandia 1
Totale 3.955
Città #
Dublin 749
Jacksonville 316
Dearborn 138
Chandler 113
Hong Kong 86
Lawrence 66
Princeton 66
Wilmington 65
Piemonte 59
Beijing 47
San Mateo 47
Singapore 47
Ann Arbor 46
Bremen 43
Boardman 35
Turin 34
Mülheim 28
Brno 24
Ashburn 22
Helsinki 20
Munich 19
Dallas 18
Milan 18
Strasbourg 18
Andover 16
Houston 16
Novara 14
Monmouth Junction 13
Woodbridge 13
Brussels 12
Nanjing 12
Zanjan 12
Rome 11
Vercelli 10
Kocmyrzów 9
Frankfurt am Main 8
Kocaeli 8
Kunming 8
Leawood 8
Amsterdam 7
Borgomanero 7
Toronto 7
Cassano Magnago 6
Falls Church 6
Norwalk 6
Seattle 6
Waanrode 6
Ardabil 5
Düsseldorf 5
Hefei 5
Radauti 5
Sacramento 5
Sannomaru 5
São Paulo 5
Cologne 4
Menlo Park 4
Trieste 4
Winchester 4
Zurich 4
Auburn Hills 3
Augusta 3
Brescia 3
Fairfield 3
Foglizzo 3
Gainesville 3
Guangzhou 3
Guarulhos 3
Nanchang 3
Pavia 3
Prague 3
Rimini 3
Stanmore 3
Almere Stad 2
Amman 2
Ankara 2
Barcelona 2
Bologna 2
Cattolica 2
Changsha 2
Concordia sulla Secchia 2
Erding 2
Flushing 2
Honolulu 2
Jinan 2
Lissone 2
Lodi 2
London 2
New York 2
Odalengo Grande 2
Orbetello 2
Palermo 2
Pardubice 2
Phoenix 2
Portland 2
Rozzano 2
Salerno 2
San Francisco 2
Soresina 2
Vancouver 2
Vigevano 2
Totale 2.495
Nome #
Acetyl-L-carnitine and Amyotrophic Lateral Sclerosis: current evidence and potential use. 131
Human neural stem cell transplantation in ALS: initial results from a phase I trial. 95
Analysis of the GCG Repeat Length in NIPA1 Gene in C9orf72-mediated ALS in a Large Italian ALS Cohort 84
Extensive genetics of ALS: a population-based study in Italy. 81
Advances in stem cell therapy for amyotrophic lateral sclerosis 80
Novel optineurin mutations in patients with familial and sporadic amyotrophic lateral sclerosis 78
Coeliac disease mimicking Amyotrophic Lateral Sclerosis. 78
ALS Phenotype Is Influenced by Age, Sex, and Genetics: A Population-Based Study 75
ATXN2 polyQ intermediate repeats are a modifier of ALS survival. 69
A case of late-onset OCD developing PLS and FTD 69
Amyotrophic Lateral Sclerosis Outcome Measures and the Role of Albumin and Creatinine: A Population-Based Study. 68
Association of a locus in the CAMTA1 gene with survival in patients with sporadic amyotrophic lateral sclerosis 68
ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion 67
Chitotriosidase and lysosomal enzymes as potential biomarkers of disease progression in amyotrophic lateral sclerosis: a survey clinic-based study. 66
Characterization of the c9orf72 GC-rich low complexity sequence in two cohorts of Italian and Turkish ALS cases 66
Transplantation of mesenchymal stem cells in ALS. 64
A case of Progressive Non-Fluent Aphasia as onset of Amyotrophic Lateral Sclerosis with FrontoTemporal Dementia 64
Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways 62
Analysis of the KIFAP3 gene in amyotrophic lateral sclerosis: a multicenter survival study 59
The multistep hypothesis of ALS revisited: The role of genetic mutations 59
Ptosis and bulbar onset: an unusual phenotype of familial ALS? 58
ATXN-2 CAG repeat expansions are interrupted in ALS patients 57
A novel peripherin gene (PRPH) mutation identified in one sporadic amyotrophic lateral sclerosis patient 56
NEK1 variants confer susceptibility to amyotrophic lateral sclerosis. 55
C9ORF72 repeat expansion in a large Italian ALS cohort: evidence of a founder effect. 55
TBK1 is associated with ALS and ALS-FTD in Sardinian patients 55
Analysis of hnRNPA1, A2/B1, and A3 genes in patients with amyotrophic lateral sclerosis 54
Intraspinal stem cell transplantation for amyotrophic lateral sclerosis: Ready for efficacy clinical trials? 54
Effect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double-blind, placebo-controlled trial 53
A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis 53
The First Case of the TARDBP p.G294V Mutation in a Homozygous State: Is a Single Pathogenic Allele Sufficient to Cause ALS? 53
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene 49
Expanding the genetic spectrum of primary familial brain calcification due to SLC2OA2 mutations: a case series 48
A rare case of conjugal amyotrophic lateral sclerosis. 47
Detection of white matter ultrastructural changes for amyotrophic lateral sclerosis characterization: A diagnostic study from DTI-derived data 47
TUBA4A gene analysis in sporadic amyotrophic lateral sclerosis: identification of novel mutations 46
Cognitive impairment across ALS clinical stages in a population-based cohort 46
Mutational analysis of VCP gene in familial amyotrophic lateral sclerosis 45
SOD1 gene mutations in Italian patients with Sporadic Amyotrophic Lateral Sclerosis (ALS) 45
Functional status and oral health in patients with amyotrophic lateral sclerosis: A cross-sectional study 45
Genetic correlation between amyotrophic lateral sclerosis and schizophrenia 45
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis 45
Identifying and predicting amyotrophic lateral sclerosis clinical subgroups: a population-based machine-learning study 43
Study protocol on the safety and feasibility of a normocaloric ketogenic diet in people with amyotrophic lateral sclerosis 42
Screening of the PFN1 gene in sporadic amyotrophic lateral sclerosis and in frontotemporal dementia. 41
A prospective longitudinal study on the microbiota composition in amyotrophic lateral sclerosis 41
Non-invasive ventilation after surgery in amyotrophic lateral sclerosis 40
Mesenchymal stromal cell transplantation in amyotrophic lateral sclerosis: a long-term safety study 39
Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: a phase I clinical trial 39
High frequency of TARDBP gene mutations in Italian patients with amyotrophic lateral sclerosis 39
Mutations of FUS gene in sporadic amyotrophic lateral sclerosis 39
Regional spreading of symptoms at diagnosis as a prognostic marker in amyotrophic lateral sclerosis: A population-based study 39
The Potential Role of Peripheral Oxidative Stress on the Neurovascular Unit in Amyotrophic Lateral Sclerosis Pathogenesis: A Preliminary Report from Human and In Vitro Evaluations 39
Ubiquilin 2 mutations in Italian patients with amyotrophic lateral sclerosis and frontotemporal dementia. 38
Variations in the coding and regulatory sequences of the angiogenin (ANG) gene are not associated to ALS (amyotrophic lateral sclerosis) in the Italian population 38
MRI imaging and clinical features of sciatic nerve injection injury 37
The prevention of falls in patients with Parkinson's disease with in-home monitoring using a wearable system: a pilot study protocol 36
No association of DPP6 with amyotrophic lateral sclerosis in an Italian population 36
The Role of Tau beyond Alzheimer’s Disease: A Narrative Review 36
Stem cells therapy for ALS 35
Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study 35
VPS54 genetic analysis in ALS Italian cohort 35
Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis 35
Exome-wide rare variant analysis identifies TUBA4A mutations associated with familial ALS 34
Telehealth in neurodegenerative diseases: Opportunities and challenges for patients and physicians 34
Neurological emergency at the COVID-19 pandemic: report from a referral hospital in Eastern Piedmont, Italy 34
Telehealth Approach For Amyotrophic Lateral Sclerosis Patients: The experience during COVID-19 pandemic 33
Predicting functional impairment trajectories in amyotrophic lateral sclerosis: a probabilistic, multifactorial model of disease progression 33
Neuroinflammatory Pathways in the ALS-FTD Continuum: A Focus on Genetic Variants 27
Adopting Assistive Technologies in Healthcare Processes: A Chatbot for Patients with Amyotrophic Lateral Sclerosis 27
Accelerated early progression of amyotrophic lateral sclerosis over the covid-19 pandemic 27
Clinical relevance of single-subject brain metabolism patterns in amyotrophic lateral sclerosis mutation carriers 22
A Telehealth Intervention for Nutritional Counseling in Amyotrophic Lateral Sclerosis Patients 22
Decline of cognitive and behavioral functions in amyotrophic lateral sclerosis: a longitudinal study 21
Critical illness neuro-myopathy (CINM) and focal amyotrophy in intensive care unit (ICU) patients with SARS-CoV-2: a case series 21
Exploring the phenotype of Italian patients with ALS with intermediate ATXN2 polyQ repeats 21
Metal(loid)s role in the pathogenesis of amyotrophic lateral sclerosis: Environmental, epidemiological, and genetic data 20
Clinical and Metabolic Signature of UNC13A rs12608932 Variant in Amyotrophic Lateral Sclerosis 19
The Need for Biomarkers in the ALS-FTD Spectrum: A Clinical Point of View on the Role of Proteomics 18
Immunity in amyotrophic lateral sclerosis: blurred lines between excessive inflammation and inefficient immune responses 17
Gastrointestinal Status and Microbiota Shaping in Amyotrophic Lateral Sclerosis: A New Frontier for Targeting? 17
Interplay between immunity and amyotrophic lateral sclerosis: Clinical impact 16
Plateaus in amyotrophic lateral sclerosis progression: results from a population-based cohort 16
Generation of an induced pluripotent stem cell line, CSSi011-A (6534), from an Amyotrophic lateral sclerosis patient with heterozygous L145F mutation in SOD1 gene 16
Effects of acetyl L-carnitine on oxidative stress in Amyotrophic Lateral Sclerosis patients: evaluation on plasma markers and on members of the neurovascular unit 15
Amyotrophic lateral sclerosis regional progression intervals change according to time of involvement of different body regions 14
Mutational Analysis of Known ALS Genes in an Italian Population-Based Cohort 14
Potential role of vitamin D levels in amyotrophic lateral sclerosis cognitive impairment 14
Respiratory support in a population-based ALS cohort: Demographic, timing and survival determinants 13
Exposure to electromagnetic fields does not modify neither the age of onset nor the disease progression in ALS patients 13
What is amyotrophic lateral sclerosis prevalence? 13
Association of Copresence of Pathogenic Variants Related to Amyotrophic Lateral Sclerosis and Prognosis 12
Reply to: Amyotrophic lateral sclerosis with depression, cognitive impairment, and mortality 12
New Insights into the Relationship between Nutrition and Neuroinflammation in Alzheimer's Disease: Preventive and Therapeutic Perspectives 12
Do ecological factors influence the clinical presentation of amyotrophic lateral sclerosis? 12
Tailoring patients' enrollment in ALS clinical trials: the effect of disease duration and vital capacity cutoffs 12
G-CSF (filgrastim) treatment for amyotrophic lateral sclerosis: protocol for a phase II randomised, double-blind, placebo-controlled, parallel group, multicentre clinical study (STEMALS-II trial) 11
Shotgun Proteomics Links Proteoglycan-4+ Extracellular Vesicles to Cognitive Protection in Amyotrophic Lateral Sclerosis 10
Factors predicting disease progression in C9ORF72 ALS patients 10
Cell therapy in ALS: An update on preclinical and clinical studies 9
Totale 4.087
Categoria #
all - tutte 24.338
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.338


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020553 0 0 46 1 88 90 114 25 65 54 67 3
2020/2021445 55 2 55 2 55 13 86 18 70 13 68 8
2021/2022562 32 8 54 67 27 10 18 13 43 17 149 124
2022/20231.502 77 74 55 24 103 107 47 66 819 18 79 33
2023/2024602 55 36 75 33 91 20 89 8 10 7 54 124
2024/202582 41 41 0 0 0 0 0 0 0 0 0 0
Totale 4.142